Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biodegradable multilayer nanocapsules for the delivery of biologically active agents in target cells

Biodegradable multilayer nanocapsules for the delivery of biologically active agents in target cells

US Patent 11957794 · Granted Apr 16, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified Cas9 system having a dominant negative effector on non-homologous end-j2025
Modified Cas9 system having a dominant negative effector on non-homologous end-j2025
Chimeric antigen receptors that bind to prostate specific membrane antigen2025
Chimeric antigen receptors that bind to prostate specific membrane antigen2025
Sequence specific reagents targeting CCR5 in primary hematopoietic cells2023
Sequence specific reagents targeting CCR5 in primary hematopoietic cells2023
Chlorhexidine crystal forms and uses thereof in medicine2023
Method for characterization of modifications caused by the use of designer nucle2022
Core-shell composite material2022
Biodegradable multilayer nanocapsules for the delivery of biologically active ag2022
Biodegradable multilayer nanocapsules for the delivery of biologically active ag2022
Biodegradable multilayer nanocapsules for the delivery of biologically active ag2022